Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies.
Saved in:
| Title: | Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies. |
|---|---|
| Authors: | Qi Z; From Global Companion Diagnostics, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Qi, Feng, Khambata-Ford)., Ha T; Research & Development, Thermo Fisher Scientific, Carlsbad, California (Ha, Velasco Roth)., Feng W; From Global Companion Diagnostics, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Qi, Feng, Khambata-Ford)., Karnoub M; Biostatistics, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Karnoub)., Pereira K; Global Oncology R&D, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Pereira)., Shiga R; Global Oncology R&D, Daiichi Sankyo, Co, Ltd, Shinagawa, Japan (Shiga)., Smit EF; the Faculty of Medicine Division 2 Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands (Smit)., Goto Y; the Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan (Y Goto, K Goto)., De Langen AJ; the Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands (De Langen)., Goto K; the Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan (Y Goto, K Goto)., Velasco Roth AM; Research & Development, Thermo Fisher Scientific, Carlsbad, California (Ha, Velasco Roth)., Khambata-Ford S; From Global Companion Diagnostics, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Qi, Feng, Khambata-Ford). |
| Source: | Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2025 Jun 01; Vol. 149 (6), pp. 542-549. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet ISSN: 1543-2165 (Electronic) Linking ISSN: 00039985 NLM ISO Abbreviation: Arch Pathol Lab Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39299708 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Qi+Z%22">Qi Z</searchLink>; From Global Companion Diagnostics, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Qi, Feng, Khambata-Ford).<br /><searchLink fieldCode="AU" term="%22Ha+T%22">Ha T</searchLink>; Research & Development, Thermo Fisher Scientific, Carlsbad, California (Ha, Velasco Roth).<br /><searchLink fieldCode="AU" term="%22Feng+W%22">Feng W</searchLink>; From Global Companion Diagnostics, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Qi, Feng, Khambata-Ford).<br /><searchLink fieldCode="AU" term="%22Karnoub+M%22">Karnoub M</searchLink>; Biostatistics, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Karnoub).<br /><searchLink fieldCode="AU" term="%22Pereira+K%22">Pereira K</searchLink>; Global Oncology R&D, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Pereira).<br /><searchLink fieldCode="AU" term="%22Shiga+R%22">Shiga R</searchLink>; Global Oncology R&D, Daiichi Sankyo, Co, Ltd, Shinagawa, Japan (Shiga).<br /><searchLink fieldCode="AU" term="%22Smit+EF%22">Smit EF</searchLink>; the Faculty of Medicine Division 2 Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands (Smit).<br /><searchLink fieldCode="AU" term="%22Goto+Y%22">Goto Y</searchLink>; the Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan (Y Goto, K Goto).<br /><searchLink fieldCode="AU" term="%22De+Langen+AJ%22">De Langen AJ</searchLink>; the Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands (De Langen).<br /><searchLink fieldCode="AU" term="%22Goto+K%22">Goto K</searchLink>; the Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan (Y Goto, K Goto).<br /><searchLink fieldCode="AU" term="%22Velasco+Roth+AM%22">Velasco Roth AM</searchLink>; Research & Development, Thermo Fisher Scientific, Carlsbad, California (Ha, Velasco Roth).<br /><searchLink fieldCode="AU" term="%22Khambata-Ford+S%22">Khambata-Ford S</searchLink>; From Global Companion Diagnostics, Daiichi Sankyo, Inc, Basking Ridge, New Jersey (Qi, Feng, Khambata-Ford). – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227607091%22">Archives of pathology & laboratory medicine</searchLink> [Arch Pathol Lab Med] 2025 Jun 01; Vol. 149 (6), pp. 542-549. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Validation Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22College+of+American+Pathologists%22">College of American Pathologists </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7607091 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1543-2165 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200039985%22">00039985 </searchLink><i>NLM ISO Abbreviation: </i>Arch Pathol Lab Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39299708 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.5858/arpa.2024-0014-OA Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 542 Titles: – TitleFull: Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Qi Z – PersonEntity: Name: NameFull: Ha T – PersonEntity: Name: NameFull: Feng W – PersonEntity: Name: NameFull: Karnoub M – PersonEntity: Name: NameFull: Pereira K – PersonEntity: Name: NameFull: Shiga R – PersonEntity: Name: NameFull: Smit EF – PersonEntity: Name: NameFull: Goto Y – PersonEntity: Name: NameFull: De Langen AJ – PersonEntity: Name: NameFull: Goto K – PersonEntity: Name: NameFull: Velasco Roth AM – PersonEntity: Name: NameFull: Khambata-Ford S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1543-2165 Numbering: – Type: volume Value: 149 – Type: issue Value: 6 Titles: – TitleFull: Archives of pathology & laboratory medicine Type: main |
| ResultId | 1 |
